Full-Time

Senior Medical Director

Client Engagement and Virtual Care Outcomes Research

Posted on 9/27/2025

Teladoc Health - Providers

Teladoc Health - Providers

5,001-10,000 employees

Integrated virtual care platform for providers

Compensation Overview

$225k - $250k/yr

+ Performance Bonus

No H1B Sponsorship

Remote in USA

Remote

Candidates must be based in the USA.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Data Analysis
Requirements
  • MD or DO degree with active, unrestricted medical license.
  • Board certification in Internal Medicine, Family Medicine, or a specialty that treats a broad range of cardiometabolic chronic conditions.
  • Minimum 3 years of post-training clinical experience.
  • Demonstrated experience in clinical research, with several peer-reviewed publications as first and senior author.
  • Strong understanding of clinical trial design, data analysis, and regulatory compliance.
  • Exceptional oral and written communication skills, with the ability to present complex clinical concepts and health outcomes data to non-clinical stakeholders.
  • Proficiency with virtual care platforms and digital health technologies.
  • Strong understanding and experience in clinical quality, patient safety, implementation science, and value-based care delivery.
  • Exemplary cross-functional collaboration skills with physicians and other clinicians, quality and safety professionals, clinical researchers, data scientists, and commercial colleagues.
  • Ability to thrive in a highly dynamic, fast-paced environment, balancing multiple competing priorities.
Responsibilities
  • Serve as a medical liaison for clients, presenting and explaining clinical outcomes, quality metrics, and insights about opportunities for population health improvement.
  • Participate in client meetings, finalist presentations, and quarterly business reviews as a clinical thought leader (virtually and in-person).
  • Partner with product, marketing, and sales teams to translate clinical value into business outcomes for enterprise clients.
  • Present on behalf of the organization at conferences, advisory boards, and other industry forums.
  • Contribute to white papers, articles and externally facing thought leadership materials that strengthen the company’s reputation as a clinical leader.
  • Promote the clinical rigor, quality, and patient safety of our virtual care programs to external stakeholders.
  • Serve as the physician leader of the research team, partnering and mentoring a team of other researchers, analysts, and solution designers.
  • Design, conduct, and publish original research studies for our virtual care delivery solutions.
  • Partner with internal analytics, clinical, product, strategy, and marketing teams to shape insights into compelling stories that demonstrate clinical value.
  • Develop research protocols, secure IRB approval, conduct research with the highest ethical standards.
  • Analyze data, prepare manuscripts, and collaborate with colleagues to submit findings to journals, conferences, and other forms of research amplification.
  • Present novel research at key industry and/or academic clinical conferences.
  • Collaborate with academic partners and internal teams to advance evidence-based virtual care models and support our evolution into a Learning Health System.
  • Mentor internal clinical staff on research methodology and manuscript preparation.
Desired Qualifications
  • MPH or additional advanced health, statistical, policy or research-related degree strongly preferred.
  • Experience delivering virtual care and digital health, particularly primary care and for cardiometabolic conditions (beyond COVID-19 pandemic).
  • Experience partnering with employer groups, payers or health systems in a consultative or advisory capacity.
  • Experience in commercial roles such as medical affairs, business development, or health technology consulting.
  • Track record of grant writing or securing research funding.
  • Familiarity with value-based care contracting and healthcare economics.
  • Established network within academic medicine or digital health research communities.
Teladoc Health - Providers

Teladoc Health - Providers

View

Teladoc Health offers virtual healthcare through an integrated platform that connects patients with providers for both episodic and long-term care worldwide. It serves individuals, employers, health plans, hospitals, and health systems, generating revenue from subscriptions and per-visit fees. The company runs brands like BetterHelp, Livongo, and InTouch Health to cover mental health, chronic condition management, and hospital solutions. It uses real-time data from connected devices to deliver evidence-based care at scale and coordinate care across different settings, aiming to improve access to high-quality, personalized healthcare globally.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

2002

Simplify Jobs

Simplify's Take

What believers are saying

  • BetterHelp insurance expands to 30 states, targeting $125M run-rate by 2026 year-end.
  • Integrated Care grows 4.7% in Q4 2025 with 101.8M US members.
  • AI-driven 24/7 care upgrades counter subscription-to-visit shifts by 2026.

What critics are saying

  • Amazon Clinic erodes subscription revenue with cheaper primary care visits in 6-12 months.
  • Medicare telehealth expiration cuts chronic care reimbursements, dropping 10-15% membership in 6-12 months.
  • Pineal Capital forces $200M buyback, diluting AI investments in 3-6 months.

What makes Teladoc Health - Providers unique

  • Teladoc Health integrates AI, analytics, and telehealth devices for evidence-based virtual care.
  • BetterHelp provides direct-to-consumer mental health matching in 20+ languages across 175 countries.
  • Catapult Health acquisition in 2025 enhances employer-sponsored primary care screenings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Performance Bonus

Company News

The Associated Press
Mar 31st, 2026
Pineal Capital urges Teladoc to launch $200M+ buyback as activist warns of takeover risk

Pineal Capital Management has issued an open letter to Teladoc Health's board urging immediate action to unlock shareholder value, warning the telehealth company is vulnerable to an opportunistic takeover at its current depressed valuation of approximately 4.18 times 2026 EV/EBITDA. The investment firm, a Teladoc shareholder, criticised the board's slow pace of action despite months of engagement. Pineal highlighted past missteps including the overvalued Livongo acquisition and persistent share dilution, with basic shares outstanding rising from 90 million in 2020 to 177 million by December 2025. Pineal proposed a three-part value-unlock plan: further cost cuts, a $200 million-plus share buyback programme, and a strategic review potentially separating Teladoc's Integrated Care and BetterHelp segments. The firm noted recent policy changes and BetterHelp's insurance-payor model, expected to reach a $100 million revenue run-rate in 2026, as significant growth catalysts.

Yahoo Finance
Mar 19th, 2026
Teladoc stock drops 31.6% in six months as revenue growth stalls and customer spending falls

Teladoc shares have fallen 31.6% over six months to $5.44, driven by softer quarterly results. Despite the lower valuation, analysts identify three concerns with the telehealth company. First, Teladoc's long-term revenue growth of 1.7% compounded annually over three years falls below expectations. Second, average revenue per user has declined at 8.5% annually over two years, suggesting weakening customer engagement. Third, Wall Street analysts project revenue growth will stall over the next 12 months. The stock currently trades at 4.3× forward EV/EBITDA. While the valuation appears reasonable, analysts believe Teladoc's weaker fundamentals present downside risk. They suggest investors consider alternative opportunities with stronger growth prospects instead.

Yahoo Finance
Mar 1st, 2026
Teladoc guides flat 2026 revenue at $2.47B–$2.59B, targets $75M–$90M insurance revenue for BetterHelp

Teladoc Health reported fourth-quarter revenue of $642 million and full-year revenue of $2.53 billion, down 1.5% year-over-year. The company guided 2026 consolidated revenue flat at $2.47 billion to $2.59 billion, with free cash flow of $130 million to $170 million. Results showed divergent segment performance. Integrated Care grew 4.7% in Q4 with 16% adjusted EBITDA margin, whilst BetterHelp declined 6.7% in Q4 and 9% for the full year. Management is targeting $75 million to $90 million in 2026 insurance revenue for BetterHelp. Teladoc closed 2025 with $781 million cash and retired $550 million in convertible debt. The company is focusing on AI-driven product innovation, including enhanced 24/7 care offerings and new data tools to improve chronic-care targeting and mental-health matching.

Yahoo Finance
Feb 26th, 2026
Teladoc shares jump 13.5% on narrower Q4 loss despite soft 2026 guidance

Teladoc Health shares jumped 13.5% after the digital healthcare platform reported fourth-quarter results that exceeded analyst expectations. The company posted revenue of $642.3 million, slightly above forecasts, whilst narrowing its quarterly loss per share to $0.14 from $0.28 in the prior year period. Despite guidance for the first quarter and full year 2026 coming in below analyst expectations, investors focused on the strong quarterly performance and improved profitability. The company has faced recent challenges including a nearly 19% year-over-year decline in BetterHelp monthly active users and concerns over expiring Medicare telehealth reimbursements. Teladoc shares are down 24.5% year-to-date, trading at $5.32, approximately 51.6% below their 52-week high of $10.99.

Yahoo Finance
Feb 26th, 2026
Teladoc reports $2.53B revenue with $167M free cash flow despite BetterHelp's 9% decline

Teladoc Health reported Q4 2025 revenue of $642 million with adjusted EBITDA of $84 million, representing a 13% margin. Full-year consolidated revenue reached $2.53 billion, down 1.5% year-over-year, with free cash flow of $167 million. The company's Integrated Care segment grew 4.7% year-over-year to $409 million, driven by performance-based revenue and increased virtual care visits. However, BetterHelp revenue declined 6.7% to $233 million in Q4, with a 9% full-year decline to $950 million. Teladoc ended 2025 with $781 million in cash after retiring $550 million in convertible debt. The company expects a $5 million to $7 million headwind from tariffs in 2026 and anticipates modest declines in US membership due to government programme reductions.

INACTIVE